
Novo Nordisk has decided to donate insulin and hemophilia drugs to last Ukraine’s health authority up to two months, the company reports on its website.
”We are doing all we can to maintain the supply of essential medicines to patients living with chronic diseases in Ukraine,” the website reads, also stating that the company has donated EUR 7.4m to Ukrainian refugees, with some funds allocated to Ukrainians with a connection to the firm, while EUR 700,000 of the amount was donated to the UN’s refugee agency, UNHCR.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app